Cahaba Research, Inc. ( Site 2523) — Birmingham, Alabama

Cahaba Research, Inc. ( Site 2523) is a clinical research site located in Birmingham, Alabama, United States 35235.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cahaba Research, Inc. ( Site 2523) has participated in 1 clinical trials.

Therapeutic areas: Coronavirus Disease (COVID-19).

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cahaba Research, Inc. ( Site 2523)?

Cahaba Research, Inc. ( Site 2523) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cahaba Research, Inc. ( Site 2523) conducted?

Cahaba Research, Inc. ( Site 2523) has 1 clinical trials on record. Their work covers Coronavirus Disease (COVID-19).

Is Cahaba Research, Inc. ( Site 2523) accredited by Crixeo Health?

Cahaba Research, Inc. ( Site 2523) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cahaba Research, Inc. ( Site 2523)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.